Coordinated early immune response in the lungs is required for effective control of SARS-CoV-2 replication

Journal:
Nature Communications
Published:
DOI:
10.1038/s41467-025-60885-0
Affiliations:
7
Authors:
11
Go to article
Institutions Authors Share
Karolinska Institute (KI), Sweden
5.666667
 0.52
Novavax, Inc., United States of America (USA)
4.000000
 0.36
Karolinska University Hospital, Sweden
1.333333
 0.12
Interested in Clinical Sciences?